Praxis Precision Medicines (PRAX) Operating Income (2022 - 2025)
Historic Operating Income for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to -$78.4 million.
- Praxis Precision Medicines' Operating Income fell 3787.1% to -$78.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$293.1 million, marking a year-over-year decrease of 7870.93%. This contributed to the annual value of -$200.2 million for FY2024, which is 5839.22% down from last year.
- Praxis Precision Medicines' Operating Income amounted to -$78.4 million in Q3 2025, which was down 3787.1% from -$76.1 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Operating Income ranged from a high of -$25.5 million in Q3 2023 and a low of -$78.4 million during Q3 2025
- Over the past 4 years, Praxis Precision Medicines' median Operating Income value was -$44.3 million (recorded in 2022), while the average stood at -$51.4 million.
- In the last 5 years, Praxis Precision Medicines' Operating Income soared by 4467.46% in 2023 and then crashed by 13000.79% in 2024.
- Praxis Precision Medicines' Operating Income (Quarter) stood at -$41.5 million in 2022, then skyrocketed by 32.92% to -$27.8 million in 2023, then tumbled by 130.01% to -$64.0 million in 2024, then fell by 22.52% to -$78.4 million in 2025.
- Its last three reported values are -$78.4 million in Q3 2025, -$76.1 million for Q2 2025, and -$74.7 million during Q1 2025.